Routine Anticoagulation Seems Warranted After TMVR: Review
(UPDATED) Evidence on the risk of valve thrombosis and the best way to manage it is still limited, however.
(UPDATED) Evidence on the risk of valve thrombosis and the best way to manage it is still limited, however.
The 2025 SCAI Scientific Sessions will be held May 1st-3rd, 2025 in Washington, DC. Login to view Sessions and Papers saved as favorites. View schedules,…
In collaboration with the other members of the Regulatory Relief Coalition (RRC), SCAI has written to Senators Green, Murphy, and Schrier, thanking them for their…
The SCAI’s Mentor Connect program is a community-building initiative and professional development opportunity for all participating interventional cardiologists. For a mentor, this is your opportunity…
High blood pressure is a leading risk factor for heart disease and stroke, affecting nearly half of US adults and contributing to 685,875 deaths in…
The recommendations are similar to those recently announced for TTVR, with the final NCD for T-TEER expected by July.
SCAI and Boston Scientific India Educare are pleased to announce the continuation of the leading-edge webinar series HealConclave: Form & Function. This series has been…
SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions. Feedback is requested by October 16th. The Society for Cardiovascular Angiography and Interventions is…
High blood pressure is a leading risk factor for heart disease and stroke, affecting nearly half of US adults and contributing to 685,875 deaths in…